Maryland Capital Management Sangamo Therapeutics, Inc Transaction History

Maryland Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$5.23 - $7.82 $105,578 - $157,862	-20,187 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$7.29 - $10.97 $9,054 - $13,624	1,242 Added 6.56%	20,187 $151,000
Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $9,938 - $13,247	1,103 Added 6.18%	18,945 $171,000
Q2 2021 Aug 13, 2021	SELL	$10.17 - $12.64 $19,526 - $24,268	-1,920 Reduced 9.72%	17,842 $214,000
Q1 2021 May 11, 2021	BUY	$10.88 - $17.05 $215,010 - $336,942	19,762 New	19,762 $248,000

134

86.5M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $266M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

Stay updated on Maryland Capital Management with notifications on news.